|
[1]
|
Panuganti, K.K., Nguyen, M. and Kshirsagar, R.K. (2023) Obesity. StatPearls Publishing Copyright, Treasure Is-land.
|
|
[2]
|
World Health Organization (2014) Global Status Report on Noncommunicable Diseases 2014. World Health Organization, Geneva.
|
|
[3]
|
Conway, B. and Rene, A. (2004) Obesity as a Disease: No Lightweight Matter. Obesity Re-views, 5, 145-151. [Google Scholar] [CrossRef]
|
|
[4]
|
Stępień, M., Stępień, A., Wlazeł, R.N., Paradowski, M., Banach, M. and Rysz, J. (2014) Obesity Indices and Inflammatory Markers in Obese Non-Diabetic Normo- and Hyper-tensive Patients: A Comparative Pilot Study. Lipids in Health and Disease, 13, Article No. 29. [Google Scholar] [CrossRef]
|
|
[5]
|
司原成, 苗维纳, 何嘉悦, 等. 肥胖-肠道菌群-Toll样受体交互调控作用的研究进展[J]. 世界华人消化杂志, 2016, 24(15): 2361-2367.
|
|
[6]
|
Arias-Loste, M.T., et al. (2016) In-creased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Mor-bidly Obese Patients with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 17, 1878. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
张梦捷, 孙爱平, 李慧, 等. Toll样受体与肥胖[J]. 中国免疫学杂志, 2018, 34(9): 1428.
|
|
[8]
|
Miura, K., Ishioka, M. and Iijima, K. (2017) The Roles of the Gut Microbiota and Toll-Like Receptors in Obesity and Nonalcoholic Fatty Liver Disease. Journal of Obesity & Metabolic Syndrome, 26, 86-96. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Chen, L., Zheng, L.L., Chen, P.Q. and Liang, G. (2020) Myeloid Differentiation Primary Response Protein 88 (MyD88): The Central Hub of TLR/IL-1R Signaling. Journal of Medicinal Chemistry, 63, 13316-13329. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Lin, X. and Li, H. (2021) Obesity: Epidemiology, Pathophysi-ology, and Therapeutics. Frontiers in Endocrinology (Lausanne), 12, Article ID: 706978. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Longo, M., et al. (2019) Adipose Tissue Dysfunction as Determi-nant of Obesity-Associated Metabolic Complications. International Journal of Molecular Sciences, 20, 2358. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Engin, A. (2017) The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation. Advances in Experimental Medicine and Biology, 960, 221-245. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Tilg, H. and Moschen, A.R. (2008) Inflammatory Mechanisms in the Regulation of Insulin Resistance. Molecular Medicine, 14, 222-231. [Google Scholar] [CrossRef]
|
|
[14]
|
Ellulu, M.S., Patimah, I., Khaza’ai, H., Rahmat, A. and Abed, Y. (2017) Obesity and Inflammation: The Linking Mechanism and the Complications. Archives of Medical Science, 13, 851-863. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Mi, S., et al. (2019) Expression of TLR4/MyD88/NF-κB Pathway Genes and Its Related Inflammatory Factors in Secondary Spinal Cord Injury. Journal of Zhejiang University. Medical Sciences, 48, 609-616.
|
|
[16]
|
Sindhu, S., Thomas, R., Shihab, P., Sriraman, D., Behbehani, K. and Ahmad, R. (2015) Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation. PLOS ONE, 10, e0133494. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Kawai, T., Autieri, M.V. and Scalia, R. (2021) Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity. American Journal of Physiology-Cell Physiology, 320, C375-C391. [Google Scholar] [CrossRef] [PubMed]
|